Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 19Unknown 12Terminated 9Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 10380INDUSTRY 3281OTHER_GOV 285NIH 226NETWORK 162FED 33UNKNOWN 3INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Cancer 1

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × INDIV × Interventional × Clear all
NCT07123415 2025-11-19

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Aptabio Therapeutics, Inc.

Phase 1 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡